Learn about Bevatas Injection 400 mg, a bevacizumab concentrate for solution for infusion used in oncology care under medical supervision. Product profile, usage information, safety, storage, regulatory documentation, and Primecare Impex contact details. Bevatas Injection 400 mg – Bevacizumab 400mg/16ml Concentrate for Solution for Infusion for Oncology Care Bevatas Injection 400 mg contains Bevacizumab, a monoclonal antibody used in oncology treatment. It is supplied as a concentrate for solution for infusion and is intended for administration by qualified healthcare professionals in a hospital, oncology clinic, or supervised medical setting. Bevatas belongs to the category of targeted anticancer medicines. Unlike traditional chemotherapy that directly attacks rapidly dividing cells, bevacizumab works by targeting a growth factor involved in the formation of new blood vessels. This helps reduce the blood supply that tumors may need to grow and spread. Basic Product Details Brand Name: Bevatas Generic Name: Bevacizumab Strength: 400 mg / 16 ml Dosage Form: Concentrate for solution for infusion Packing Size: 1 vial Therapeutic Category: Anticancer medicine Route of Administration: Intravenous infusion only Use: Oncology treatment under doctor supervision Bevacizumab is a targeted cancer therapy known as an anti-VEGF monoclonal antibody. VEGF stands for vascular endothelial growth factor, a protein that supports the growth of new blood vessels. Some tumors depend on new blood vessel formation to receive oxygen and nutrients. By blocking VEGF activity, bevacizumab may help slow tumor progression in specific cancers when used as part of a doctor-prescribed treatment plan. Bevatas Injection 400 mg should not be used without a valid medical prescription, oncology evaluation, and professional administration. Bevatas Injection 400 mg contains bevacizumab, which is used in oncology care for selected cancer types depending on the approved indication, local treatment guidelines, and oncologist decision. Bevacizumab may be used in treatment plans for certain cases of: Metastatic colorectal cancer Non-squamous non-small cell lung cancer Recurrent glioblastoma Renal cell carcinoma Ovarian, fallopian tube, or primary peritoneal cancer Cervical cancer Other doctor-approved oncology indications depending on country-specific regulations The actual use depends on medical evaluation, cancer diagnosis, biomarker status where relevant, previous therapy, and local regulatory approval. Bevatas works through the active ingredient bevacizumab. Cancer cells may stimulate the body to create new blood vessels. This process is called angiogenesis. New blood vessels can help tumors receive oxygen and nutrients. Bevacizumab binds to VEGF and reduces its ability to support new blood vessel formation. By blocking VEGF activity, bevacizumab may help limit tumor blood supply and slow cancer growth when used as part of an appropriate oncology treatment plan. This is why bevacizumab is known as an anti-angiogenic targeted therapy. Why Choose Primecare Impex? Primecare Impex supports medicine-related enquiries with a focus on professional communication, product information, documentation awareness, and regulatory compliance. Primecare Impex Highlights Pharmaceutical exporter from India Supplier and distributor support Oncology product information assistance Professional product profile support Documentation-focused communication International enquiry support WhatsApp and email assistance Clear product details for healthcare-related requirements Compliance-aware communication for regulated medicines Bevatas Injection 400 mg product information Bevatas 400 mg bevacizumab injection details Bevacizumab 400mg 16ml concentrate for infusion Bevatas Injection 400 mg oncology medicine profile Bevatas 400 mg anticancer infusion information Bevacizumab concentrate for solution for infusion 400 mg Bevatas 400 mg vial information for oncology care Bevacizumab targeted therapy information Bevatas Injection 400 mg safety and storage details Bevacizumab anti VEGF monoclonal antibody information Bevatas 400mg/16ml infusion product profile Bevatas Injection 400 mg clinical use overview Bevacizumab infusion administration information Bevatas Injection 400 mg for oncologist-supervised treatment Bevatas 400 mg storage and handling information Bevacizumab anticancer medicine information page Bevatas Injection 400 mg Washington information Bevatas Injection 400 mg London UK information Bevatas Injection 400 mg Riyadh Saudi Arabia information Contact Primecare Impex — Pharmaceutical Exporter from India For product-related information and professional enquiries, contact Primecare Impex. Website: www.medicineexporterfromindia.com Email: raakeshkashiwar@gmail.com Business Type: Exporter | Supplier | Distributor WhatsApp: +91 9673008130 WhatsApp Link: https://wa.me/919673008130